Article

  • The EMBO Journal (2001) 20, 743 - 754
  • doi:10.1093/emboj/20.4.743

Phospholipase Cepsilon: a novel Ras effector

Grant G. Kelley1, Sarah E. Reks1, Joanne M. Ondrako1 and Alan V. Smrcka2

  1. Departments of Medicine and Pharmacology, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
  2. Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 711, Rochester, NY 14642, USA

Correspondence to:

Grant G. Kelley, E-mail: kelleyg@mail.upstate.edu

Received 7 November 2000; Accepted 22 December 2000; Revised 20 December 2000


Three classes of mammalian phosphoinositide-specific phospholipase C (PLC) have been characterized, PLCbeta, PLCgamma and PLCdelta, that are differentially regulated by heterotrimeric G-proteins, tyrosine kinases and calcium. Here we describe a fourth class, PLCepsilon, that in addition to conserved PLC domains, contains a GTP exchange factor (GRF CDC25) domain and two C-terminal Ras-binding (RA) domains, RA1 and RA2. The RA2 domain binds H-Ras in a GTP-dependent manner, comparable with the Ras-binding domain of Raf-1; however, the RA1 domain binds H-Ras with a low affinity in a GTP-independent manner. While Galphaq, Gbetagamma or, surprisingly, H-Ras do not activate recombinant purified protein in vitro, constitutively active Q61L H-Ras stimulates PLCepsilon co-expressed in COS-7 cells in parallel with Ras binding. Deletion of either the RA1 or RA2 domain inhibits this activation. Site-directed mutagenesis of the RA2 domain or Ras demonstrates a conserved Ras–effector interaction and a unique profile of activation by Ras effector domain mutants. These studies identify a novel fourth class of mammalian PLC that is directly regulated by Ras and links two critical signaling pathways.

  • Keywords:

    • GTP-binding protein Ras,
    • GTP exchange factor,
    • phospholipase C,
    • Raf-1,
    • Ras-binding domain